Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Histogen Inc. stock logo
HSTO
Histogen
$0.00
$0.02
$0.05
$0.55
$1K1.1910,369 shsN/A
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
$0.00
+50.0%
$0.00
$0.00
$0.13
$30K1.758,709 shs8,000 shs
Smart for Life, Inc. stock logo
SMFL
Smart for Life
$0.01
+192.5%
$0.01
$0.00
$3.31
$83K16.776,537 shs996 shs
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$3.64
-2.7%
$4.45
$2.51
$2,465.94
$157K1.43315,940 shs7,950 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Histogen Inc. stock logo
HSTO
Histogen
0.00%-97.00%-75.00%-98.97%-99.86%
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
+50.00%-70.00%-57.14%-50.00%-70.00%
Smart for Life, Inc. stock logo
SMFL
Smart for Life
-68.25%-68.25%-38.46%+11.11%-99.82%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
+1.88%-1.58%-12.82%+14.02%-99.83%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Histogen Inc. stock logo
HSTO
Histogen
N/AN/AN/AN/AN/AN/AN/AN/A
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/AN/AN/AN/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Histogen Inc. stock logo
HSTO
Histogen
0.00
N/AN/AN/A
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
0.00
N/AN/AN/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
0.00
N/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Histogen Inc. stock logo
HSTO
Histogen
$19K0.07N/AN/A$3.13 per share0.00
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
$8.13K3.69N/AN/AN/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
$11.11M0.01N/AN/A($17.10) per share0.00
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$19.29M0.01N/AN/A$163.50 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Histogen Inc. stock logo
HSTO
Histogen
-$10.62M-$2.81N/AN/AN/AN/AN/AN/A
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
-$15.18MN/A0.00N/AN/AN/AN/AN/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
-$22.68MN/A0.00N/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
-$6.16MN/A0.00N/AN/AN/AN/AN/A

Latest HSTO, UPC, NAVB, and SMFL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/11/2025Q3 2024
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/A-$0.94N/A-$0.94N/A$1.27 million
5/23/2025Q2 2024
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/A-$2.41N/A-$2.34N/A$0.88 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Histogen Inc. stock logo
HSTO
Histogen
N/AN/AN/AN/AN/A
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
N/AN/AN/AN/AN/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Histogen Inc. stock logo
HSTO
Histogen
N/A
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
0.01%
Smart for Life, Inc. stock logo
SMFL
Smart for Life
28.39%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.18%

Insider Ownership

CompanyInsider Ownership
Histogen Inc. stock logo
HSTO
Histogen
3.30%
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
43.68%
Smart for Life, Inc. stock logo
SMFL
Smart for Life
31.71%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
57.38%
CompanyEmployeesShares OutstandingFree FloatOptionable
Histogen Inc. stock logo
HSTO
Histogen
204.27 millionN/ANot Optionable
Navidea Biopharmaceuticals, Inc. stock logo
NAVB
Navidea Biopharmaceuticals
10100.08 million56.37 millionOptionable
Smart for Life, Inc. stock logo
SMFL
Smart for Life
1107.09 million4.84 millionNot Optionable
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
22043,000731,000Not Optionable

Recent News About These Companies

UPC’s Unexpected Plunge: What’s Next?
Universe Pharmaceuticals gets Nasdaq delisting notice
Universe Pharmaceuticals Files Registration for 37.5 Million Shares

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Histogen stock logo

Histogen NASDAQ:HSTO

$0.0003 0.00 (0.00%)
As of 07/7/2025

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

Navidea Biopharmaceuticals stock logo

Navidea Biopharmaceuticals NYSE:NAVB

$0.0003 +0.00 (+50.00%)
As of 07/8/2025 01:30 PM Eastern

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It develops NAV3-31, which has completed Phase IIb clinical trials for evaluating imaging repeatability, reproducibility, and stability, as well as the capacity of Tc99m tilmanocept imaging for treatment of anti-tumor necrosis factor alpha therapy in patients with moderate to severe rheumatoid arthritis (RA); NAV3-35 that is in a Phase IIb clinical trial for RA imaging; NAV3-33, which is in Phase III clinical trial for RA; and NAV3-32, which is Phase 2b trial for RA-involved joints. The company is also developing Tc99m tilmanocept for cardiovascular, kaposi's sarcoma, tuberculosis, and other immunotherapeutic applications. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio.

Smart for Life stock logo

Smart for Life NASDAQ:SMFL

$0.01 +0.01 (+192.50%)
As of 10:17 AM Eastern

Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements under the Smart for Life brand; dietary supplements; and nutritional products, including whey protein isolate powder, tablet supplements for joint health, nitric oxide, post workout blends, Omega-3 supplements, and pre-workout supplements under the Sports Illustrated Nutrition brand for athletes and active lifestyle consumers. The company also provides various nutritional products, including antioxidant rich supplements, plant-based proteins, alkalizing nutrients, and weight management products. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Boca Raton, Florida.

Universe Pharmaceuticals stock logo

Universe Pharmaceuticals NYSE:UPC

$3.64 -0.10 (-2.67%)
Closing price 03:59 PM Eastern
Extended Trading
$3.70 +0.06 (+1.79%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.